Journal of Diabetes Research
Scope & Guideline
Leading the way in diabetes research and innovation.
Introduction
Aims and Scopes
- Diabetes Pathophysiology and Mechanisms:
Research exploring the underlying biological mechanisms of diabetes, including insulin resistance, beta-cell dysfunction, and genetic factors influencing disease progression. - Clinical Management and Treatment Strategies:
Studies evaluating various treatment modalities for diabetes, including pharmacological interventions, lifestyle modifications, and emerging therapies such as GLP-1 receptor agonists and SGLT-2 inhibitors. - Diabetes Complications:
Research focused on the complications associated with diabetes, such as cardiovascular disease, diabetic retinopathy, nephropathy, and neuropathy, and their management. - Public Health and Epidemiology:
Investigations into the epidemiology of diabetes, including prevalence, risk factors, and the impact of diabetes on public health, particularly in diverse populations. - Innovative Technologies in Diabetes Management:
Studies that assess the application of new technologies, such as continuous glucose monitoring and telemedicine, in improving diabetes care and patient outcomes. - Nutritional and Lifestyle Interventions:
Research examining the role of diet, physical activity, and behavioral interventions in diabetes prevention and management. - Integrative and Traditional Medicine Approaches:
Exploration of complementary and alternative medicine approaches, including traditional Chinese medicine, in the treatment of diabetes.
Trending and Emerging
- Diabetes and COVID-19 Interactions:
Research examining the relationship between diabetes and COVID-19, including the impact of diabetes on disease severity and outcomes, has gained significant traction in response to the pandemic. - Precision Medicine and Genomics:
Studies focusing on the genetic and genomic aspects of diabetes, including personalized medicine approaches that tailor treatment based on individual genetic profiles, are increasingly prevalent. - Machine Learning and Artificial Intelligence:
The application of machine learning and AI in predicting diabetes outcomes, optimizing treatment regimens, and enhancing patient monitoring is an emerging area of focus, reflecting the integration of technology in healthcare. - Behavioral Health and Diabetes Distress:
There is a growing emphasis on the psychological aspects of diabetes management, including diabetes distress and the impact of mental health on treatment adherence and outcomes. - Microbiome and Diabetes:
Research exploring the gut microbiome's role in diabetes pathogenesis and management is on the rise, highlighting the importance of microbiota in metabolic health. - Telemedicine and Remote Patient Monitoring:
The advancement and implementation of telehealth solutions for diabetes management have gained momentum, especially post-pandemic, emphasizing the need for accessible healthcare solutions.
Declining or Waning
- Basic Science Research:
There has been a noticeable decrease in basic science studies that solely focus on cellular and molecular mechanisms of diabetes without direct clinical implications. This shift may be due to an increasing emphasis on translational research that bridges laboratory findings with clinical applications. - Historical Epidemiological Studies:
Research that reviews historical data or trends in diabetes prevalence and outcomes appears to be waning. This could be attributed to a shift towards more contemporary, real-time data analysis and the need for immediate applicability in clinical settings. - Pharmacotherapy Comparisons:
Comparative studies of older diabetes medications are becoming less frequent as newer agents and combination therapies gain prominence in diabetes management discussions. - Conventional Dietary Interventions:
Studies focusing solely on traditional dietary interventions without incorporating modern nutritional science or technology are becoming less common, as there's a trend towards personalized nutrition and integrative approaches.
Similar Journals
JOURNAL OF DIABETES AND ITS COMPLICATIONS
Transforming knowledge into action against diabetes complications.JOURNAL OF DIABETES AND ITS COMPLICATIONS is a distinguished peer-reviewed journal published by Elsevier Science Inc, dedicated to advancing the knowledge and management of diabetes and its multifaceted complications. With an ISSN of 1056-8727 and E-ISSN 1873-460X, this journal has established its significance in the fields of Endocrinology, Diabetes and Metabolism, and Internal Medicine, as reflected in its Q2 and Q1 quartile rankings for 2023, and its commendable Scopus rankings. The journal, which has been converging knowledge since 1992 and continues to publish vital research until 2024, serves as a platform for researchers, professionals, and students aiming to delve deeper into the mechanisms, treatment, and implications of diabetes and its related disorders. While access is not open, the journal remains a critical resource for those invested in understanding and combating the challenges posed by diabetes, ultimately contributing to better health outcomes.
Diabetologie
Pioneering insights in diabetes and metabolism.Diabetologie is a dedicated academic journal published by Springer Heidelberg, focusing on the diverse fields of endocrinology, diabetes, and metabolism. With the ISSN 2731-7447 and E-ISSN 2731-7455, this journal serves as a significant platform for the dissemination of innovative research and evidence-based practices within the rapidly evolving landscape of diabetes care and management. Although currently not classified as Open Access, the journal provides robust subscription options that grant access to a wealth of peer-reviewed articles, making it an invaluable resource for researchers and practitioners alike. With an H-index that reflects its emerging influence and a Scopus ranking in the 10th percentile within its category, Diabetologie aims to elevate the scientific understanding of diabetes through rigorous scholarship. The journal captures the latest findings and clinical advancements from 2022 to 2024, placing a particular emphasis on novel therapeutic strategies and technological innovations. By fostering a collaborative environment dedicated to the improvement of diabetes outcomes, Diabetologie stands as a crucial contributor to the global dialogue on diabetes treatment and research.
Primary Care Diabetes
Enhancing understanding of diabetes through collaborative scholarship.Primary Care Diabetes is a leading journal published by ELSEVIER SCI LTD, focusing on the intersection of diabetes care, endocrinology, and family medicine. Since its inception in 2007, the journal has made significant contributions to the field, achieving notable rankings in various categories, such as Q2 in Endocrinology, Diabetes and Metabolism, Q1 in Family Practice, and Q2 in Internal Medicine, as well as Nutrition and Dietetics for 2023. With an ISSN of 1751-9918 and an E-ISSN of 1878-0210, it serves as an essential resource for researchers, healthcare professionals, and students dedicated to advancing knowledge and practice in primary diabetes care. The journal's strong Scopus rankings reflect its commitment to publish high-quality research, fostering clinical practice improvements and enhanced patient outcomes. Although not open access, its articles are pivotal for anyone looking to stay ahead in the dynamic and vital domain of diabetes management.
Diabetology International
Empowering researchers to shape the future of diabetes.Diabetology International, published by Springer Japan KK, is a leading journal dedicated to the field of diabetes research. With an ISSN of 2190-1678 and E-ISSN of 2190-1686, this journal plays a pivotal role in disseminating innovative studies and findings that advance understanding in endocrinology, diabetes, and metabolism. Its rigorous peer-review process ensures the publication of high-quality research articles, review papers, and clinical studies, making it a valuable resource for researchers, healthcare professionals, and students. The journal is indexed in Scopus and maintains respectable rankings in its categories, standing at Q3 in Endocrinology, Diabetes and Metabolism, and Q2 in Internal Medicine as of 2023. Furthermore, the journal facilitates collaborations and promotes the exchange of ideas from its base in Tokyo, Japan, helping to bridge the gap between academia and clinical practice. As it converges through the years from 2010 to 2024, Diabetology International remains committed to addressing the evolving challenges in diabetes care and research, supporting the global community's pursuit of knowledge in this crucial field.
Diabetes Mellitus
Innovating therapeutic strategies for diabetes management.Diabetes Mellitus, published by the Endocrinology Research Centre in the Russian Federation, is an esteemed open-access journal dedicated to the field of endocrinology, diabetes, and metabolism. Since its inception in 1998, this journal has been a pivotal platform for disseminating cutting-edge research and comprehensive reviews that address the multifaceted challenges posed by diabetes. With its current quartile ranking of Q4 in Endocrinology and the associated fields, as well as commendable involvement in the broader scope of Internal Medicine, Diabetes Mellitus plays a crucial role in enhancing clinical practices and informing innovative therapeutic strategies. The journal caters to a diverse audience of researchers, healthcare professionals, and students, particularly those seeking to expand their knowledge and improve patient outcomes in diabetes care. With a commitment to fostering scientific conversation and collaboration, Diabetes Mellitus is an invaluable resource for anyone engaged in the fight against diabetes and its complications.
Cardiovascular Diabetology
Advancing the Frontiers of Cardiovascular and Diabetes ResearchCardiovascular Diabetology is a prestigious open-access journal published by BMC, focusing on the intersecting fields of cardiology, endocrinology, diabetes, and internal medicine. Since its inception in 2002, this journal has established itself as a vital resource for researchers, clinicians, and academics dedicated to advancing knowledge in these areas. With an impressive impact factor reflected in its Q1 rankings for the year 2023 across its respective categories, including a ranking of 22nd in Cardiology and Cardiovascular Medicine and notably 15th in Internal Medicine, it positions itself at the forefront of scholarly communication. The journal encourages the dissemination and sharing of groundbreaking research, providing open access to foster engagement and collaboration among professionals globally. As it converges from 2002 to 2024, Cardiovascular Diabetology continues to be a pivotal platform for innovative studies, reviews, and critical insights that significantly impact clinical practices and medical education in the evolving landscape of cardiovascular health and diabetes management.
Journal of Diabetes Investigation
Fostering innovation in diabetes investigation.Journal of Diabetes Investigation is a prestigious open-access journal published by WILEY, dedicated to advancing knowledge in the fields of Endocrinology, Diabetes, and Metabolism. With its ISSN 2040-1116 and E-ISSN 2040-1124, the journal provides a vital platform for researchers, healthcare professionals, and students to disseminate high-quality research, foster innovative ideas, and engage with cutting-edge developments in diabetes investigation. Since its inception in 2010, the journal has established a solid reputation, ranking in Q2 for Endocrinology and Diabetes and Metabolism, and Q1 for both Internal Medicine and Miscellaneous Medicine categories in 2023. Its Scopus rankings further underscore its impact, notably at the 76th percentile in Internal Medicine. The open access model, adopted in 2014, ensures that vital information is freely available, promoting global collaboration and knowledge sharing. The journal is not only a reflection of Australia's commitment to medical research but also a beacon for advancements that can ultimately enhance patient outcomes in diabetes care.
DIABETES
Advancing knowledge, transforming diabetes care.DIABETES, published by the American Diabetes Association, is a premier journal in the field of endocrinology, diabetes, and metabolism, renowned for its rigorous peer-reviewed research since its inception in 1952. With an impressive impact factor and classified in the Q1 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine as of 2023, it holds a prestigious position within the scholarly community, ranked 17th out of 244 in its specialization. The journal's objective is to disseminate cutting-edge research and advance scientific understanding to ultimately improve diabetes patient care and management. While it does not offer open access options, the journal remains a vital resource for researchers, professionals, and students involved in diabetes-related studies. The ongoing dedication to excellence by the authors, reviewers, and editors ensures that DIABETES continues to be a pivotal platform for innovation and knowledge in the fight against diabetes.
ACTA DIABETOLOGICA
Elevating Standards in Diabetes ResearchACTA DIABETOLOGICA, published by SPRINGER-VERLAG ITALIA SRL, is a distinguished peer-reviewed journal dedicated to the rapidly evolving fields of endocrinology, diabetes, and metabolism. With an impressive convergence of research from 1991 to 2024, it is recognized for its significant contributions, boasting a Q1 ranking in Internal Medicine and Q2 rankings in Endocrinology categories as of 2023. Its Scopus rankings further highlight its impact, placing it in the 81st percentile in Internal Medicine. The journal serves as a vital platform for professionals and researchers, facilitating the dissemination of innovative findings and fostering a comprehensive understanding of metabolic disorders. Although the journal is not open access, it remains an essential resource, ensuring high visibility and accessibility of critical research to its scholarly audience.
DIABETES CARE
Elevating standards in diabetes and metabolic research.DIABETES CARE, published by the American Diabetes Association, is a premier journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 1978, this journal has maintained a commitment to disseminating high-quality research, evidenced by its prestigious ranking in the Q1 category across multiple fields including Advanced and Specialized Nursing, Endocrinology, Diabetes and Metabolism, and Internal Medicine. With an impressive impact factor and distinguished Scopus rankings, DIABETES CARE serves as an essential resource for researchers, clinicians, and students alike, facilitating the exchange of knowledge and fostering innovation in diabetes care. Although not an open-access publication, the journal offers various ways to access groundbreaking studies and advancements in the field. This commitment to excellence reflects the journal's vital role in shaping diabetes research and clinical practices globally.